SEC Form 4 · accession 0001104659-15-085014
EPIRUS Biopharmaceuticals, Inc. · EPRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Munshi
Officer — Chief Executive Officer · Director
Period of report
Dec 15, 2015
Accepted (ET)
Dec 16, 2015 · 8:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001135906
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 15, 2015 | P | 8,069 | $2.87 | A | 161,712 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All shares are held by the Amit D Munshi Revocable Trust Dated April 12, 2011, for which the Reporting Person serves as trustee.